Literature DB >> 11483271

Antigenic and molecular heterogeneity in recent swine influenza A(H1N1) virus isolates with possible implications for vaccination policy.

J C de Jong1, P P Heinen, W L Loeffen, A P van Nieuwstadt, E C Claas, T M Bestebroer, K Bijlsma, C Verweij, A D Osterhaus, G F Rimmelzwaan, R A Fouchier, T G Kimman.   

Abstract

In order to explore the occurrence of antigenic drift in swine influenza A(H1N1) viruses and the match between epidemic and vaccine strains, 26 virus isolates from outbreaks of respiratory disease among finishing pigs in the Netherlands in the 1995/1996 season and reference strains from earlier outbreaks were examined using serological and molecular methods. In contrast to swine H3N2 viruses, no significant antigenic drift was observed in swine H1N1 viruses isolated from the late 1980s up to 1996 inclusive. However, a marked antigenic and genetic heterogeneity in haemagglutination inhibition tests and nucleotide sequence analyses was detected among the 26 recent swine H1N1 virus strains. Interestingly, the observed antigenic and molecular variants were not randomly distributed over the farms. This finding indicates independent introductions of different swine H1N1 virus variants at the various farms of the study and points to a marked difference between the epidemiologies of human and swine influenza viruses. The observed heterogeneity may hamper the control of swine influenza by vaccination and indicates that the efficacy of current swine influenza vaccines requires re-evaluation and that the antigenic reactivity of swine influenza viruses should be monitored on a regular basis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11483271     DOI: 10.1016/s0264-410x(01)00190-6

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.

Authors:  Jürgen A Richt; Porntippa Lekcharoensuk; Kelly M Lager; Amy L Vincent; Christina M Loiacono; Bruce H Janke; Wai-Hong Wu; Kyoung-Jin Yoon; Richard J Webby; Alicia Solórzano; Adolfo García-Sastre
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

2.  Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets.

Authors:  Berend Jan Bosch; Rogier Bodewes; Robert P de Vries; Joost H C M Kreijtz; Willem Bartelink; Geert van Amerongen; Guus F Rimmelzwaan; Cornelis A M de Haan; Albert D M E Osterhaus; Peter J M Rottier
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

3.  The evolutionary dynamics of influenza A virus adaptation to mammalian hosts.

Authors:  S Bhatt; T T Lam; S J Lycett; A J Leigh Brown; T A Bowden; E C Holmes; Y Guan; J L N Wood; I H Brown; P Kellam; O G Pybus
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-04       Impact factor: 6.237

4.  Molecular modeling of swine influenza A/H1N1, Spanish H1N1, and avian H5N1 flu N1 neuraminidases bound to Tamiflu and Relenza.

Authors:  Ly Le; Eric Lee; Klaus Schulten; Thanh N Truong
Journal:  PLoS Curr       Date:  2009-08-27

5.  Prevalence of and risk factors for influenza in southern Ontario swine herds in 2001 and 2003.

Authors:  Zvonimir Poljak; Catherine E Dewey; S Wayne Martin; Jette Christensen; Susy Carman; Robert M Friendship
Journal:  Can J Vet Res       Date:  2008-01       Impact factor: 1.310

6.  Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin.

Authors:  Bin Wang; Hai Yu; Fu-Ru Yang; Meng Huang; Ji-Hong Ma; Guang-Zhi Tong
Journal:  Virol J       Date:  2012-06-27       Impact factor: 4.099

7.  State feedback impulsive therapy to SIS model of animal infectious diseases.

Authors:  Qiong Liu; Meng Zhang; Lansun Chen
Journal:  Physica A       Date:  2018-10-18       Impact factor: 3.263

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.